Medicus Pharma Ltd.
MDCX
$0.26
$0.013.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -88.11% | -77.21% | -417.37% | -818.76% | -70.00% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 440.47% | 733.51% | 4,560.17% | 50,108.74% | -50.89% |
| Change in Net Operating Assets | 997.87% | -203.29% | 138.34% | -56.46% | 58.06% |
| Cash from Operations | -27.70% | -127.60% | -107.08% | -117.85% | -96.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 388.89% | -- | -- | -- | -13.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -7.03% | 164.53% | 313.52% | -- | 27.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.84% | -- | -- | -- | -- |
| Cash from Financing | 128.85% | 81.56% | 224.61% | -- | 4.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.03% | -1,186.20% | 103.77% | 67.52% | -27.70% |